In conclusion, we revealed that Evr effectively impaired the growth of GEM-resistant pancreatic cancer cells, both in vitro and in vivo, by regulating the PI3K/AKT/mTOR signaling pathway. This evidence concerns the gene AKT1 and pancreatic neoplasm.